Oral Session

[O-47] Neuroimmunology 2 (MS and NMO)

Sat. May 25, 2019 10:15 AM - 11:45 AM Room 12 (Osaka International Convention Center 11F Conference Room 1101-1102)

Chair:Makoto Matsui(Department of Neurology, Kanazawa Medical University) Commentator:Youwei Lin(Dep.of Neurology, National Center Hospital and Dep.of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

+Add all to schedule

[O-47-1] Changes of disease activities in NMO spectrum disorders over time - a 28-year observational study

Etsuji Saji, Takahiro Wakasugi, Fumihiro Yanagimura, Kaori Yanagawa, Mariko Hokari, Masatoyo Nishizawa, Osamu Onodera, Izumi Kawachi (Department of Neurology, Brain Research Institute, Niigata University, Japan)

[O-47-2] The analysis of the monocyte role in NMO with patient-derived AQP4 recombinant antibody

Mikito Shimizu¹, Makoto Kinoshita¹, Toru Koda¹, Akiko Namba¹, Kazuya Yamashita¹, Teruyuki Ishikura¹, Yuji Nakatsuji², Hideki Mochizuki¹, Tatsusada Okuno¹ (1.Department of neurology, Osaka university graduate school of medicine, Japan, 2.Depertment of Neurology, Toyama University Hospital)

[O-47-3] Chemokines associated with early relapse after fingolimod withdrawal in multiple sclerosis

Yusei Miyazaki^1,2, Masaaki Niino¹, Eri Takahashi¹, Toshiyuki Fukazawa³, Kazunori Sato³, Moemi Yamada³, Shintaro Fujii², Itaru Amino², Fumihito Nakano², Sachiko Akimoto², Naoya Minami², Shizuki Doi², Seiji Kikuchi² (1.Department of Clinical Research, Hokkaido Medical Center, Japan, 2.Department of Neurology, Hokkaido Medical Center, Japan, 3.Sapporo Neurology Hospital, Japan)

[O-47-4] Relationship between cognitive impairments and specific brain region volume in MS and NMOSD patients

Ryouhei Komaki¹, Tomoko Okamoto¹, Yukio Kimura², Manabu Araki^1,3, Youwei Lin^1,3, Wakiro Sato³, Takashi Yamamura³, Yuji Takahashi¹ (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Department of Radiology, National Center Hospital, National Center of Neurology and Psychiatry, 3.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)

[O-47-5] A clinically-based acore predicting cryptogenic new-onset refractory status epilepticus (C-NORSE)

Atsuko Yanagida¹, Takahiro Iizuka¹, Juntaro Kaneko¹, Atsushi Kaneko¹, Yutaka Nonoda², Yuya Onozawa³, Naomi Kanazawa¹, Kazutoshi Nishiyama¹ (1.Department of Neurology, Kitasato University School of Medicine, Japan, 2.Department of Pediatrics, Kitasato University School of Medicine, 3.Department of Clinical Laboratory, Kitasato University Hospital)

[O-47-6] Endothelial damage in patients with neuromyelitis optica spectrum disorder with aquaporin-4 IgG

Hiroshi Kuroda¹, Yoshiki Takai¹, Shuhei Nishiyama¹, Toshiyuki Takahashi¹, Tatsuro Misu^1,4, Ichiro Nakashima², Kazuo Fujihara^3,4, Masashi Aoki¹ (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Neurology, Tohoku Medical and Pharmatheutical University, 3.Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, 4.Multiple Sclerosis Therapeutics, Tohoku University Graduate School of Medicine)